The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Repression of E-cadherin by the polycomb group protein EZH2 in cancer
Open accessAbstract
Enhancer of zeste homolog 2 (EZH2) is a critical component of the polycomb-repressive complex 2 (PRC2), which is involved in gene silencing and histone H3 lysine 27 methylation. EZH2 has a master regulatory function in controlling such processes as stem cell differentiation, cell proliferation, early embryogenesis and X chromosome inactivation. Although benign epithelial cells express very low levels of EZH2, increased levels of EZH2 have been observed in aggressive solid tumors such as those of the prostate, breast and bladder. The mechanism by which EZH2 mediates tumor aggressiveness is unclear. Here, we demonstrate that EZH2 mediates transcriptional silencing of the tumor suppressor gene E-cadherin by trimethylation of H3 lysine 27. Histone deacetylase inhibitors can prevent EZH2-mediated repression of E-cadherin and attenuate cell invasion, suggesting a possible mechanism that may be useful for the development of therapeutic treatments. Taken together, these observations provide a novel mechanism of E-cadherin regulation and establish a functional link between dysregulation of EZH2 and repression of E-cadherin during cancer progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vandesompele, J., De Preter, K., Pattyn, F., Poppe, B., Van Roy, N., De Paepe, A., & Speleman, F. (2002) · Genome Biology · doi:10.1186/gb-2002-3-7-research0034 · Cited by 20,038
Role of Histone H3 Lysine 27 Methylation in Polycomb-Group Silencing
Cao, R., Wang, L., Wang, H., Xia, L., Erdjument-Bromage, H., Tempst, P., Jones, R. S., & Zhang, Y. (2002) · Science · doi:10.1126/science.1076997 · Cited by 3,775
The polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
Self-citationBatlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Polycomb complexes repress developmental regulators in murine embryonic stem cells
Boyer, L. A., Plath, K., Zeitlinger, J., Brambrink, T., Medeiros, L. A., Lee, T. I., Levine, S. S., Wernig, M., Tajonar, A., Ray, M. K., et al. (2006) · Nature · doi:10.1038/nature04733 · Cited by 2,514
Control of Developmental Regulators by Polycomb in Human Embryonic Stem Cells
Lee, T. I., Jenner, R. G., Boyer, L. A., Guenther, M. G., Levine, S. S., Kumar, R. M., Chevalier, B., Johnstone, S. E., Cole, M. F., Isono, K.-I., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.043 · Cited by 2,268
The Polycomb group protein EZH2 directly controls DNA methylation
Viré, E., Brenner, C., Deplus, R., Blanchon, L., Fraga, M., Didelot, C., Morey, L., Van Eynde, A., Bernard, D., Vanderwinden, J.-M., et al. (2006) · Nature · doi:10.1038/nature04431 · Cited by 2,204
Kleer, C. G., Cao, Q., Varambally, S., Shen, R., Ota, I., Tomlins, S. A., Ghosh, D., Sewalt, R. G. A. B., Otte, A. P., Hayes, D. F., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1933744100 · Cited by 1,649
Self-citationE-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells.
Frixen, U. H., Behrens, J., Sachs, M., Eberle, G., Voss, B., Warda, A., Löchner, D., & Birchmeier, W. (1991) · The Journal of cell biology · doi:10.1083/jcb.113.1.173 · Cited by 1,551
Polycomb silencers control cell fate, development and cancer
Sparmann, A., & van Lohuizen, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1991 · Cited by 1,303
Genome-wide mapping of Polycomb target genes unravels their roles in cell fate transitions
Bracken, A. P., Dietrich, N., Pasini, D., Hansen, K. H., & Helin, K. (2006) · Genes & Development · doi:10.1101/gad.381706 · Cited by 1,257
Schlesinger, Y., Straussman, R., Keshet, I., Farkash, S., Hecht, M., Zimmerman, J., Eden, E., Yakhini, Z., Ben-Shushan, E., Reubinoff, B. E., et al. (2007) · Nature Genetics · doi:10.1038/ng1950 · Cited by 1,226 · cited 1×
“Cancer cells that contain DNA-methylated genes are specifically packaged in nuclesomes with the histone H3K27 trimethylation (Schlesinger et al., 2007).”
BackgroundRole of Histone H3 Lysine 27 Methylation in X Inactivation
Plath, K., Fang, J., Mlynarczyk-Evans, S. K., Cao, R., Worringer, K. A., Wang, H., de la Cruz, C. C., Otte, A. P., Panning, B., & Zhang, Y. (2003) · Science · doi:10.1126/science.1084274 · Cited by 1,195
Epigenetic stem cell signature in cancer
Widschwendter, M., Fiegl, H., Egle, D., Mueller-Holzner, E., Spizzo, G., Marth, C., Weisenberger, D. J., Campan, M., Young, J., Jacobs, I., et al. (2007) · Nature Genetics · doi:10.1038/ng1941 · Cited by 1,143
Ohm, J. E., McGarvey, K. M., Yu, X., Cheng, L., Schuebel, K. E., Cope, L., Mohammad, H. P., Chen, W., Daniel, V. C., Yu, W., et al. (2007) · Nature Genetics · doi:10.1038/ng1972 · Cited by 1,130
Cadherins in development: cell adhesion, sorting, and tissue morphogenesis
Halbleib, J. M., & Nelson, W. J. (2006) · Genes & Development · doi:10.1101/gad.1486806 · Cited by 1,064
The SLUG zinc-finger protein represses E-cadherin in breast cancer.
Hajra, K. M., Chen, D. Y., & Fearon, E. R. (2002) · PubMed · Cited by 1,020
Tan, J., Yang, X., Zhuang, L., Jiang, X., Chen, W., Lee, P. L., Karuturi, R. K. M., Tan, P. B. O., Liu, E. T., & Yu, Q. (2007) · Genes & Development · doi:10.1101/gad.1524107 · Cited by 895 · cited 2×
“, 2005), as well as in vitro cancer cell lines such as SKBR3, MDA-MB-231, T47D breast cell lines (Tan et al., 2007) and the prostate cell lines DU145 and LNCaP (Beke et al.”
BackgroundBachmann, I. M., Halvorsen, O. J., Collett, K., Stefansson, I. M., Straume, O., Haukaas, S. A., Salvesen, H. B., Otte, A. P., & Akslen, L. A. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.5180 · Cited by 851
Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex
Fujita, Y., Krause, G., Scheffner, M., Zechner, D., Leddy, H. E. M., Behrens, J., Sommer, T., & Birchmeier, W. (2002) · Nature Cell Biology · doi:10.1038/ncb758 · Cited by 846
Peinado, H., Ballestar, E., Esteller, M., & Cano, A. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.1.306-319.2004 · Cited by 763
A prognostic index in primary breast cancer
Haybittle, J. L., Blamey, R. W., Elston, C. W., Johnson, J., Doyle, P. J., Campbell, F. C., Nicholson, R. I., & Griffiths, K. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.62 · Cited by 699
Oka, H., Shiozaki, H., Kobayashi, K., Inoue, M., Tahara, H., Kobayashi, T., Takatsuka, Y., Matsuyoshi, N., Hirano, S., & Takeichi, M. (1993) · PubMed · Cited by 661
Kondo, Y., Shen, L., Cheng, A. S., Ahmed, S., Boumber, Y., Charo, C., Yamochi, T., Urano, T., Furukawa, K., Kwabi-Addo, B., et al. (2008) · Nature Genetics · doi:10.1038/ng.159 · Cited by 620
Decreased E-cadherin expression is associated with poor prognosis in patients with prostate cancer.
Umbas, R., Isaacs, W. B., Bringuier, P., Schaafsma, H. E., Karthaus, H. F. M., Oosterhof, G. O. N., Debruyne, F. M. J., & Schalken, J. A. (1994) · PubMed · Cited by 529
van der Vlag, J., & Otte, A. P. (1999) · Nature Genetics · doi:10.1038/70602 · Cited by 527
Differential loss of E-cadherin expression in infiltrating ductal and lobular breast carcinomas.
Moll, R., Mitze, M., Frixen, U. H., & Birchmeier, W. (1993) · PubMed · Cited by 520
Silencing of human polycomb target genes is associated with methylation of histone H3 Lys 27
Kirmizis, A., Bartley, S. M., Kuzmichev, A., Margueron, R., Reinberg, D., Green, R., & Farnham, P. J. (2004) · Genes & Development · doi:10.1101/gad.1200204 · Cited by 495
E-cadherin—catenin cell—cell adhesion complex and human cancer
Wijnhoven, B. P. L., Dinjens, W. N. M., & Pignatelli, M. (2000) · Journal of British Surgery · doi:10.1046/j.1365-2168.2000.01513.x · Cited by 451
Mayer, B., Johnson, J. P., Leitl, F., Jauch, K. W., Heiss, M. M., Schildberg, F. W., Birchmeier, W., & Funke, I. (1993) · PubMed · Cited by 440
Cell adhesion system and human cancer morphogenesis
Hirohashi, S., & Kanai, Y. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01485.x · Cited by 439
Damsky, C. H., Richa, J., Solter, D., Knudsen, K., & Buck, C. A. (1983) · Cell · doi:10.1016/0092-8674(83)90379-3 · Cited by 391
Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster
Tolhuis, B., Muijrers, I., de Wit, E., Teunissen, H., Talhout, W., van Steensel, B., & van Lohuizen, M. (2006) · Nature Genetics · doi:10.1038/ng1792 · Cited by 381
A Polycomb Repression Signature in Metastatic Prostate Cancer Predicts Cancer Outcome
Yu, J., Yu, J., Rhodes, D. R., Tomlins, S. A., Cao, X., Chen, G., Mehra, R., Wang, X., Ghosh, D., Shah, R. B., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-2498 · Cited by 348
Self-citationPalacios, F., Tushir, J. S., Fujita, Y., & D'Souza-Schorey, C. (2005) · Molecular and Cellular Biology · doi:10.1128/mcb.25.1.389-402.2005 · Cited by 333
Rhodes, D. R., Sanda, M. G., Otte, A. P., Chinnaiyan, A. M., & Rubin, M. A. (2003) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/95.9.661 · Cited by 271
Self-citationClinicopathological significance of EZH2 mRNA expression in patients with hepatocellular carcinoma
Sudo, T., Utsunomiya, T., Mimori, K., Nagahara, H., Ogawa, K., Inoue, H., Wakiyama, S., Fujita, H., Shirouzu, K., & Mori, M. (2005) · British Journal of Cancer · doi:10.1038/sj.bjc.6602531 · Cited by 243
Chen, H., Tu, S.-W., & Hsieh, J.-T. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m501379200 · Cited by 239
Yu, J., Cao, Q., Mehra, R., Laxman, B., Yu, J., Tomlins, S. A., Creighton, C. J., Dhanasekaran, S. M., Shen, R., Chen, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2007.10.016 · Cited by 223
Self-citationPolycomb repression: from cellular memory to cellular proliferation and cancer
Jacobs, J. J. L., & van Lohuizen, M. (2002) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/s0304-419x(02)00052-5 · Cited by 209
Epithelial (E‐) and placentae (P‐) cadherin cell adhesion molecule expression in breast carcinoma
Rasbridge, S. A., Gillett, C. E., Sampson, S. A., Walsh, F. S., & Millis, R. R. (1993) · The Journal of Pathology · doi:10.1002/path.1711690211 · Cited by 201
EZH2 promotes proliferation and invasiveness of prostate cancer cells
Bryant, R. J., Cross, N. A., Eaton, C. L., Hamdy, F. C., & Cunliffe, V. T. (2007) · The Prostate · doi:10.1002/pros.20550 · Cited by 159
EZH2 and Histone 3 Trimethyl Lysine 27 Associated with Il4 and Il13 Gene Silencing in TH1 Cells
Koyanagi, M., Baguet, A., Martens, J. H. A., Margueron, R., Jenuwein, T., & Bix, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504766200 · Cited by 155
Weikert, S., Christoph, F., Köllermann, J. W., Müller, M., Schrader, M. G., Miller, K., & Krause, H. (2005) · International Journal of Molecular Medicine · doi:10.3892/ijmm.16.2.349 · Cited by 151
Pierceall, W. E., Woodard, A. S., Morrow, J. S., Rimm, D. L., & Fearon, E. R. (1995) · PubMed · Cited by 139
Fujii, S., & Ochiai, A. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00743.x · Cited by 136
Level of expression of E-cadherin mRNA in colorectal cancer correlates with clinical outcome
Dorudi, S., Hanby, A., Poulsom, R., Northover, J. M. A., & Hart, I. (1995) · British Journal of Cancer · doi:10.1038/bjc.1995.119 · Cited by 128
Beke, L., Nuytten, M., Eynde, A. V., Beullens, M., & Bollen, M. (2007) · Oncogene · doi:10.1038/sj.onc.1210248 · Cited by 121
Breuer, R. H. J., Snijders, P. J. F., Smit, E. F., Sutedja, T. G., Sewalt, R. G. A. B., Otte, A. P., van Kemenade, F. J., Postmus, P. E., Meijer, C. J. L. M., & Raaphorst, F. M. (2004) · Neoplasia · doi:10.1593/neo.04160 · Cited by 120
Day, M. L., Zhao, X., Vallorosi, C. J., Putzi, M. J., Powell, C. T., Lin, C., & Day, K. C. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.14.9656 · Cited by 119
Polycomb group protein complexes: do different complexes regulate distinct target genes?
Satijn, D. P. E., & Otte, A. P. (1999) · Biochimica et Biophysica Acta (BBA) - Gene Structure and Expression · doi:10.1016/s0167-4781(99)00130-x · Cited by 115
Hajra, K. M., Ji, X., & Fearon, E. R. (1999) · Oncogene · doi:10.1038/sj.onc.1203336 · Cited by 112
Yamaguchi, N. H., Lichtenfels, A. J. D. F. C., Demarchi, L. M. M. F., da Silva, A. P., Garippo, A. L., Alves, V. A. F., Michelin, C., Azevedo, P. M., Moya, T., Takagaki, T. Y., et al. (2004) · American Journal of Clinical Pathology · doi:10.1309/p2cd-fgu1-u7cl-v5yr · Cited by 79
Cellular memory of transcriptional states by Polycomb-group proteins
Jacobs, J. J. L., & van Lohuizen, M. (1999) · Seminars in Cell and Developmental Biology · doi:10.1006/scdb.1999.0304 · Cited by 76
Frixen, U. H., & Nagamine, Y. (1993) · PubMed · Cited by 68
Saito, T., Oda, Y., Kawaguchi, K.-I., Sugimachi, K., Yamamoto, H., Tateishi, N., Tanaka, K., Matsuda, S., Iwamoto, Y., Ladanyi, M., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207960 · Cited by 54
Takeno, S., Noguchi, T., Fumoto, S., Kimura, Y., Shibata, T., & Kawahara, K. (2004) · American Journal of Clinical Pathology · doi:10.1309/wjl90jpem17rbuht · Cited by 48
Cited by
Kim, K. H., & Roberts, C. W. M. (2016) · Nature Medicine · doi:10.1038/nm.4036 · Cited by 1,471
The epigenetics of epithelial-mesenchymal plasticity in cancer
Tam, W. L., & Weinberg, R. A. (2013) · Nature Medicine · doi:10.1038/nm.3336 · Cited by 1,163
Covalent histone modifications — miswritten, misinterpreted and mis-erased in human cancers
Chi, P., Allis, C. D., & Wang, G. G. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2876 · Cited by 1,099
Tackling the cancer stem cells — what challenges do they pose?
Pattabiraman, D. R., & Weinberg, R. A. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4253 · Cited by 990
Molecular genetics of prostate cancer: new prospects for old challenges
Shen, M. M., & Abate-Shen, C. (2010) · Genes & Development · doi:10.1101/gad.1965810 · Cited by 946
Metadata
- Authors
- Cao, Q., Yu, J., Dhanasekaran, S. M., Kim, J. H., Mani, R.-S., Tomlins, S. A., Mehra, R., Laxman, B., Cao, X., Yu, J., Kleer, C. G., Varambally, S., & Chinnaiyan, A. M.
- Venue
- Oncogene
- Published
- 2008-09-22
- Volume
- 27
- Issue
- 58
- Pages
- 7274-7284
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W1977090021
- Cited by
- 583
- References
- 57
- FWCI
- 10.79
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.